Open access · US-GOV via ClinicalTrials.gov Clinical trial

Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia

Authors not listed

Seoul National University Hospital · 2015

Loss of proteostasis Human Randomized controlled trial

Abstract

This study is to assess the impact on the prevention of sarcopenia after taking cetylpyridinium chloride targeting the patients of pre-sarcopenia or sarcopenia over the age of 60

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-07-02 MST

Cite this

APA

Anonymous. (2015). Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia. <em>Seoul National University Hospital</em>. https://clinicaltrials.gov/study/NCT02575235

Vancouver

Anonymous. Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia. Seoul National University Hospital. 2015.

BibTeX

@misc{anon2015Random, title = {Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia}, author = {Anonymous}, journal = {Seoul National University Hospital}, year = {2015}, }